← All organizations

AO GENERIUM

For profit

Also known as: AO GENERIUM | JSC GENERIUM

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 7, 2024

Timeline

2000s

Jun 1, 2009
AO GENERIUM— Founded

Drugs by trial phase (18 distinct, 27 trials)

Phase 3 (15 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

gnr-051

Indications

Studied for

Recent trials (48)

NCT07155499Lead sponsorPhase 1/Phase 2Oct 7, 2024
NCT06488521Lead sponsorPhase 1Jun 20, 2024
NCT06488521OfficialPhase 1Jun 20, 2024
NCT06497491OfficialPhase 3Dec 12, 2023
NCT06497491Lead sponsorPhase 3Dec 12, 2023
NCT06488664Lead sponsorPhase 3Jul 25, 2023
NCT06488664OfficialPhase 3Jul 25, 2023
NCT06475404Lead sponsorPhase 1Apr 6, 2023
NCT06475404OfficialPhase 1Apr 6, 2023
NCT06475508OfficialPhase 3Feb 13, 2023
NCT06475508Lead sponsorPhase 3Feb 13, 2023
NCT06494345Lead sponsorPhase 1Jan 15, 2023
NCT06494345OfficialPhase 1Jan 15, 2023
NCT06481189OfficialPhase 1Sep 6, 2022
NCT06481189Lead sponsorPhase 1Sep 6, 2022

Details

Founded: Moscow, RU Jun 1, 2009
Last known activity: Oct 7, 2024